Boston Scientific Cuts Annual Sales Outlook, Expects Q4 Revenue Decline
Boston Scientific shares fell 8% Wednesday and hit their lowest level since October 2022 after the medical-device maker lowered its annual sales outlook and forecast fourth-quarter revenue to decline.